Archived documents
Documents past their public comment period for FDA.
FDA ▾
PSG_050708 - Draft Guidance on Tacrolimus
0 comments
Analysis in progress
Top issues in comments
PSG_210115 - Draft Guidance on Tacrolimus
0 comments
Analysis in progress
Top issues in comments
PSG_021395 - Draft Guidance on Tiotropium Bromide
0 comments
Analysis in progress
Top issues in comments
PSG_203214 - Draft Guidance on Tofacitinib Citrate
0 comments
Analysis in progress
Top issues in comments
PSG_019594 - Draft Guidance on Ursodiol
0 comments
Analysis in progress
Top issues in comments
PSG_009218-Sol - Draft Guidance on Warfarin Sodium
0 comments
Analysis in progress
Top issues in comments
PSG_009218 - Draft Guidance on Warfarin Sodium
0 comments
Analysis in progress
Top issues in comments
PSG_218785 - Draft Guidance on Zanubrutinib
0 comments
Analysis in progress
Top issues in comments
Assessing Adhesion With Transdermal and Topical Delivery Systems for Abbreviated New Drug Applications; Revised Draft Guidance for Industry; Availability
0 comments
Analysis in progress
Top issues in comments
Assessing the Irritation and Sensitization Potential of Transdermal and Topical Delivery Systems for ANDAs Guidance for Industry DRAFT GUIDANCE
0 comments
Analysis in progress
Top issues in comments
Assessing the Irritation and Sensitization Potential of Transdermal and Topical Delivery Systems for ANDAs; Revised Draft Guidance for Industry; Availability
0 comments
Analysis in progress
Top issues in comments
Citizen Petition from Fresenius Kabi USA, LLC
0 comments
Analysis in progress
Top issues in comments